Mesenchymal stem cells (MSCs) are adult stem cells (ASCs) known for repairing damaged cells, exerting anti-inflammatory responses and producing immunoregulatory effects that can be significantly induced into insulin-producing cells (IPCs), providing an inexhaustible supply of functional β cells for cell replacement therapy and disease modeling for diabetes. MSC therapy may be the most promising strategy for diabetes mellitus because of these significant merits. In this paper, we focused on MSC therapy for diabetes.

中文翻译：

---

间充质干细胞：治疗糖尿病的绝佳候选者

间充质干细胞 (MSC) 是成体干细胞 (ASC)，以修复受损细胞、发挥抗炎反应和产生免疫调节作用而闻名，可显着诱导产生胰岛素生成细胞 (IPC)，提供取之不尽的功能性β细胞供应用于糖尿病的细胞替代疗法和疾病建模。由于这些显着优点，MSC 疗法可能是治疗糖尿病的最有希望的策略。在本文中，我们集中于MSC治疗糖尿病。